MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Iogen Oy for its I-DROP® and I-LID ’N LASH® product lines, as well as the I-RELIEFTM HOT & COLD THERAPY EYE MASK with THERMABEADSTM and the I-PEN® Tear Osmolarity System.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/79e63011-9c51-4efd-955d-e5344050359d
I-MED Pharma continues to expand access of their cutting edge OSD line through a new distribution partnership with Iogen Oy in Finland. This is in alignment with the international growth strategy that the company has defined moving forward.
Tero Rinne, Chairman of the Board of Iogen Oy commented, "We are exceedingly happy about starting our cooperation with I-MED Pharma, whose category defining products will provide great value to Finnish ophthalmologists. The diagnostic platform will also allow us to better serve our patients with more accurate therapeutic planning."
Daniel Hofmann, President of I-MED Pharma stated, “We are thrilled to be partnering with Iogen Oy, a company that shares our vision for providing both eye care professionals and dry eye patients with innovative, value-added products. We are excited that this partnership will allow for expanded access of our dry eye product line in the Finnish market and we look forward to working closely with Iogen Oy over the next several months to ensure a successful launch.”
About I-MED Pharma
I-MED Pharma Inc. is a privately held Canadian company, headquartered in Montreal, Quebec, servicing Canadian ophthalmologists, optometrists and the global eye care community. Established almost thirty years ago, I-MED Pharma creates and distributes innovative medical, surgical and veterinary eye care products worldwide. It continually researches, develops and sources the most effective and advanced solutions to eye disorders like cataracts, corneal degeneration, dry eye, glaucoma and meibomian gland dysfunction.
I-MED Pharma is proud to have been at the forefront of managing Dry Eye Syndrome as a serious disease and invests heavily into education and developing effective dry eye products. I-MED Pharma’s ocular surface disease product range includes diagnostic tools, dry eye drops, ocular hygiene, nutrition and therapeutic accessories.
Iogen Oy is the largest independent supplier in Finland for ophthalmic medical and surgical devices. The primary focus is on delivering innovations and high technology, complemented by customer-centric, consultative salesmanship based on true expertise. We are constantly looking for companies that fulfill our requirements of being innovative and bringing added value to our customers.
For more information, please email media@imedpharma.com or visit imedpharma.com.